N4 Pharma (GB:N4P) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
N4 Pharma PLC has announced that their total number of voting rights and shares in issue stands at 394,780,349, with all these being ordinary shares with no shares held in treasury. The figure is critical for shareholders to calculate changes or notifications in their company shareholdings as per FCA rules. The company specializes in developing Nuvec®, a novel delivery system for cancer treatments and vaccines and aims to monetize its advancements through partnerships, upfront and milestone payments, and eventual royalties.
For further insights into GB:N4P stock, check out TipRanks’ Stock Analysis page.
